Orient EuroPharma Co., Ltd.

NT$42.30As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4120Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 0.09%
Div yield 9.46%
ROE (7.15%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.09
PE TTM —
TSR TTM (0.33%)
Mkt cap NT$3.669B
ROIC (4.24%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$42
(0.72%)
(49.12%)
Hold 9|6|12|7|12
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.58
0.62
0.65
0.71
46.03%
41.38%
34.57%
33.30%
RevenueNT$M
189.7
200.1
211.7
218.9
(0.49%)
0.98%
9.18%
12.11%
Peers (US$110.8M)
Cap (US$)
PE
126.8M
19.58x
110.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.008
0.398
0.329
EBIT/Intx
0.549
0.495
0.539
Own earn%
609.40
268.66
217.77
Sh yield%
42.02
26.59
30.29
Owners
Insiders/Inst%
2.20
84.87
Short interest%
0.89
SBC / revenue%
4.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
20–26
$1 testx
—
Incr. ROIC%
0